A detailed history of Lion Street Advisors, LLC transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Lion Street Advisors, LLC holds 273,281 shares of CRDL stock, worth $349,799. This represents 0.19% of its overall portfolio holdings.

Number of Shares
273,281
Previous 253,281 7.9%
Holding current value
$349,799
Previous $511,000 5.87%
% of portfolio
0.19%
Previous 0.19%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$1.83 - $2.48 $36,600 - $49,600
20,000 Added 7.9%
273,281 $541,000
Q2 2024

Jul 12, 2024

BUY
$1.67 - $2.97 $101,170 - $179,925
60,581 Added 31.44%
253,281 $511,000
Q4 2023

Jan 09, 2024

BUY
$0.67 - $1.0 $129,109 - $192,700
192,700 New
192,700 $161,000

Others Institutions Holding CRDL

About Cardiol Therapeutics Inc.


  • Ticker CRDL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 61,942,500
  • Market Cap $79.3M
  • Description
  • Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...
More about CRDL
Track This Portfolio

Track Lion Street Advisors, LLC Portfolio

Follow Lion Street Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lion Street Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lion Street Advisors, LLC with notifications on news.